Rüschoff, Josef
4 papers on CoChatORCID 0000-0003-1467-8149
Most cited papers
- Verified
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet
Gastric Cancer Management and OutcomesHER2/EGFR in Cancer Research
Cited by 7,302
- Verified
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine
HER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies
Cited by 5,084
- Verified
Enhancement of experimental metastasis by tumor necrosis factor.
Orosz, P., Echtenacher, B., Falk, W., Rüschoff, J., Weber, D., & Männel, D. N. (1993) · The Journal of experimental medicine
Immune cells in cancerChemokine receptors and signaling
Cited by 198
- Verified
Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma
Heinmöller, E., Dietmaier, W., Zirngibl, H., Heinmöller, P., Scaringe, W., Jauch, K.-W., Hofstädter, F., & Rüschoff, J. (2000) · The American Journal of Pathology
Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics
Cited by 121
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free